Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
How Much Growth is Expected for the Proteasome Inhibitors Market from 2024 to 2033?
In recent times, there has been a substantial growth in the market size of proteasome inhibitors. It is projected to rise from $1.86 billion in 2023 to $2.03 billion in 2024, hunting a compound annual growth rate (CAGR) of 9.3%. The past growth can be credited to scientific breakthroughs, clinical findings and trials, approvals by the FDA, an increase in cancer instances, and improvements in the delivery of drugs.
Expectations indicate that the proteasome inhibitors market will experience robust expansion in the coming years. The projected growth tracks the market reaching a size of $2.89 billion by 2028, growing at a compound annual growth rate (CAGR) of 9.2%. This accelerating growth in the projected period can be tied to factors such as precision medicine approaches, next-generation inhibitors, the expansion of healthcare infrastructure, combinations of targeted therapies, and adoption in emerging markets. Significant trends in this forecast period are anticipated to be combinations of immunotherapy, selective proteasome inhibition, inhibitors with extended half-lives, oral formulations and treatments for resistant cancer variants.
Claim Your Free Sample of the Global Proteasome Inhibitors Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12251&type=smp
What Factors Are Encouraging Growth in the proteasome inhibitors Market?
The spike in the occurrence of pancreatic cancer is predicted to push forward the expansion of the market for proteasome inhibitors. The pancreas, a part of the abdominal system located behind the stomach, is where pancreatic cancer notably originates. The significant role of proteasome to enhance cell proliferation and prevent cell death by breaking down proteins that control cell cycle advancement makes proteasome inhibitors vital in the treatment of pancreatic cancer. The inhibitors work by impeding cancer cell survival, preventing tumor growth, and restraining metastasis. For example, the American Society of Clinical Oncology (ASCO), a US professional organization for oncology professionals, reported in March 2023 that around 64,050 adults in the US were diagnosed with pancreatic cancer in that year, and 50,550 individuals lost their lives to the disease. On a global scale in 2020, it was reported that 495,773 individuals were diagnosed, and 466,003 died from pancreatic cancer. This escalating rate of pancreatic cancer incidence propels the rise of the proteasome inhibitors market.
Which Segments Play a Vital Role in the Proteasome Inhibitors Market?
1) By Product: Velcade, Kyprolis, Ninlaro, Other Products
2) By Drugs: Bortezomib, Carfilzomib, Ixazomib
3) By Indication: Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospital, Specialty Clinics, Other End-Users
What Trends Are Driving Change in the Proteasome Inhibitors Market?
The escalation in investments is a prominent trend gaining traction in the proteasome inhibitors market. Primary companies in the proteasome inhibitors industry are funneling resources into the development and introduction of proteasome inhibitors, which hold substantial potential to propel research and bring novel treatments to the fore. For example, in September 2022, QLi5 Therapeutics GmbH, a German firm specializing in next-gen proteasome inhibitors, procured $10.96 million (EUR 10 million) from SV Investment, a South Korean venture capital business, KHAN Technology Transfer Fund I, a venture capital entity based in Germany, in addition to Atinum Investment Co., Ltd. and Daol Investment & Securities Co., Ltd., venture capital companies located in South Korea. The aim of this investment is to facilitate the creation of innovative proteasome inhibitors dedicated to the treatment of cancer and inflammatory and autoimmune conditions. Thanks to these funds, QLi5’s unique proteasome inhibitor pipeline will progress to the initial stages of clinical trials for various indications.
Order Now for Fast Delivery of Your Proteasome Inhibitors Market Report!
https://www.thebusinessresearchcompany.com/report/proteasome-inhibitors-global-market-report
What Regions Are Contributing Significantly to the Growth of the Proteasome Inhibitors Market?
North America was the largest region in the proteasome inhibitors market in 2023. The regions covered in the proteasome inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Proteasome Inhibitors Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the proteasome inhibitors market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Proteasome Inhibitors Market Include
1. Proteasome Inhibitors Market Executive Summary
2. Proteasome Inhibitors Market Segments
3. Proteasome Inhibitors Market Size And Template Market Growth Rate
4. Key Proteasome Inhibitors Market Trends
5. Major Proteasome Inhibitors Market Drivers
……
25. Key Mergers And Acquisitions In The Proteasome Inhibitors Market
26. Top Proteasome Inhibitors Companies
27. Proteasome Inhibitors Market Opportunities And Strategies
28. Proteasome Inhibitors Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Interleukin Inhibitors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/interleukin-inhibitor-global-market-report
PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2024
HER2 Inhibitors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/her2-inhibitor-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
